Speaker illustration

Doctor Daniele Rodolico

University of Pisa, Pisa (Italy)

Member of:

European Society of Cardiology
Heart Failure Association

Daniele Rodolico is a resident physician at the University of Pisa, Italy. He received his MD cum laude from the Catholic University of Milan (UCSC). He was affiliated to research at the Division of Cardiology of the Department of Medicine, Karolinska Institutet, Stockholm. He was also a Visiting Student Trainee at the University of Texas Health Science Center at Houston and a Student Intern at the Cardiovascular Research Center of the Massachusetts General Hospital in Boston under a fellowship from the Giovanni Armenise Foundation at the Harvard Medical School. In 2021, he was a finalist of the Young investigator Award for Clinical Research of the HFA. He is interested in heart failure and cardiometabolic diseases.

Representation of frailty in contemporary trials of heart failure medications: a systematic review and dose-response meta-analysis

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 5

Thumbnail

Eligibility for simultaneous initiation of the four pharmacological pillars of heart failure with reduced ejection fraction at discharge

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Acute heart failure - treatment 2

Thumbnail

Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Acute heart failure - pharmacotherapy

Thumbnail

Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: Young Investigator Award: clinical research

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb